All Relations between cannabis and cannabinoids

Publication Sentence Publish Date Extraction Date Species
Benthe H Doeve, Maartje M van de Meeberg, Fiona D M van Schaik, Herma H Fidde. A Systematic Review With Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease: What Can We Learn From Randomized and Nonrandomized Studies? Journal of clinical gastroenterology. vol 55. issue 9. 2021-10-26. PMID:32675631. a systematic review with meta-analysis of the efficacy of cannabis and cannabinoids for inflammatory bowel disease: what can we learn from randomized and nonrandomized studies? 2021-10-26 2023-08-13 Not clear
Benthe H Doeve, Maartje M van de Meeberg, Fiona D M van Schaik, Herma H Fidde. A Systematic Review With Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease: What Can We Learn From Randomized and Nonrandomized Studies? Journal of clinical gastroenterology. vol 55. issue 9. 2021-10-26. PMID:32675631. a number of studies have investigated the effectiveness of cannabis or cannabinoids for treatment of inflammatory bowel diseases (ibd). 2021-10-26 2023-08-13 Not clear
Katie Pizzolato, David Thacker, Nicole Del Toro-Pagán, Abeer Hanna, Jacques Turgeon, Adriana Matos, Nishita Amin, Veronique Michau. Cannabis Dopaminergic Effects Induce Hallucinations in a Patient with Parkinson's Disease. Medicina (Kaunas, Lithuania). vol 57. issue 10. 2021-10-26. PMID:34684144. cannabis products that contain the tetrahydrocannabinol (thc) cannabinoid are emerging as promising therapeutic agents for the treatment of medical conditions such as chronic pain. 2021-10-26 2023-08-13 Not clear
Irene Braithwaite, Chiranth Bhagavan, Marjan Doppen, Stacey Kung, Karen Oldfield, Giles Newton-Howe. Medicinal applications of cannabis/cannabinoids. Current opinion in psychology. vol 38. 2021-10-25. PMID:32652488. regulatory approvals for epidiolex (purified cannabidiol) in the treatment of childhood drug resistant epilepsy have set a precedent for the use of cannabinoids as a prescribed medicine. 2021-10-25 2023-08-13 Not clear
Jonas Carneiro Cruz, Luís Felippe Cabral Miranda, Maria Eugênia Costa Queiro. Pipette tip micro-solid phase extraction (octyl-functionalized hybrid silica monolith) and ultra-high-performance liquid chromatography-tandem mass spectrometry to determine cannabidiol and tetrahydrocannabinol in plasma samples. Journal of separation science. vol 44. issue 8. 2021-10-25. PMID:33387419. this manuscript describes the development of an innovative method to determine cannabinoids (cannabidiol and tetrahydrocannabinol) in human plasma samples by pipette tip micro-solid phase extraction and liquid chromatography-mass spectrometry/mass spectromtery. 2021-10-25 2023-08-13 human
Alexander N Melinyshyn, Farnaz Amoozega. Cannabinoid Use in a Tertiary Headache Clinic: A Cross-Sectional Survey. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2021-10-25. PMID:34511153. this study seeks to determine the prevalence and nature of cannabis use in patients with headache in a tertiary headache clinic and to explore patients' empiric experience in using cannabinoids therapeutically. 2021-10-25 2023-08-13 Not clear
Giuliano Boscutti, Vittorio Di Maso, Alessandra Marega, Ugo Gerini, Alberto Zacchi, Francesco Bianc. [Droghe d'abuso e rene]. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. vol 38. issue Suppl 77. 2021-10-25. PMID:34669304. this give us the opportunity to review the renal effects of the main drugs of abuse, highlighting the shift occured from the four "old sisters" (marijuana, cocaine, heroin and amphetamine) to the news synthetic drugs (chiefly synthetic cathinones and cannabinoids), that poses problems due to large diffusion, easy procurement, legal non-regulation and difficult analytical identification, raising medical and forensic questions. 2021-10-25 2023-08-13 Not clear
Gianmaria Magagnini, Gianpaolo Grassi, Stiina Kotirant. The Effect of Light Spectrum on the Morphology and Cannabinoid Content of Cannabis sativa L. Medical cannabis and cannabinoids. vol 1. issue 1. 2021-10-23. PMID:34676318. the effect of light spectrum on the morphology and cannabinoid content of cannabis sativa l. 2021-10-23 2023-08-13 Not clear
Magdalena Grill, Carina Hasenoehrl, Martin Storr, Rudolf Schich. Medical Cannabis and Cannabinoids: An Option for the Treatment of Inflammatory Bowel Disease and Cancer of the Colon? Medical cannabis and cannabinoids. vol 1. issue 1. 2021-10-23. PMID:34676319. medical cannabis and cannabinoids: an option for the treatment of inflammatory bowel disease and cancer of the colon? 2021-10-23 2023-08-13 human
Jürg Gertsc. The Intricate Influence of the Placebo Effect on Medical Cannabis and Cannabinoids. Medical cannabis and cannabinoids. vol 1. issue 1. 2021-10-23. PMID:34676323. the intricate influence of the placebo effect on medical cannabis and cannabinoids. 2021-10-23 2023-08-13 Not clear
Joseph V Pergolizzi, Jo Ann LeQuang, John F Bisne. Cannabinoid Hyperemesis. Medical cannabis and cannabinoids. vol 1. issue 2. 2021-10-23. PMID:34676325. cannabinoid hyperemesis syndrome (chs) is a paradoxical condition in which a long-term cannabis user suffers an episode of intractable vomiting that may last days separated by longer asymptomatic periods of weeks or months. 2021-10-23 2023-08-13 Not clear
Aleksi Mikael Markunpoika Hupl. Medical Cannabis for Adult Attention Deficit Hyperactivity Disorder: Sociological Patient Case Report of Cannabinoid Therapeutics in Finland. Medical cannabis and cannabinoids. vol 1. issue 2. 2021-10-23. PMID:34676327. medical cannabis for adult attention deficit hyperactivity disorder: sociological patient case report of cannabinoid therapeutics in finland. 2021-10-23 2023-08-13 Not clear
Paul T Kocis, Kent E Vran. Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions. Medical cannabis and cannabinoids. vol 3. issue 1. 2021-10-23. PMID:34676340. in the case of medical cannabis and medicinal cannabinoids, this is further complicated by the fact that the increased therapeutic use of marijuana extracts and cannabidiol oil will not have regulatory agency approved pi. 2021-10-23 2023-08-13 Not clear
Paul T Kocis, Kent E Vran. Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions. Medical cannabis and cannabinoids. vol 3. issue 1. 2021-10-23. PMID:34676340. in addition to a comprehensive list of drug-drug interactions, we also provide a list of 57 prescription medications displaying a narrow therapeutic index that are potentially impacted by concomitant cannabinoid use (whether through prescription use of cannabinoid medications or therapeutic/recreational use of cannabis and its extracts). 2021-10-23 2023-08-13 Not clear
Wesley M Raup-Konsavage, Nurgul Carkaci-Salli, Kelly Greenland, Robert Gearhart, Kent E Vran. Cannabidiol (CBD) Oil Does Not Display an Entourage Effect in Reducing Cancer Cell Viability in vitro. Medical cannabis and cannabinoids. vol 3. issue 2. 2021-10-23. PMID:34676344. several studies have found that cannabinoids, particularly delta-9-tetrahydrocannabinol and cannabidiol (cbd), have the ability to reduce cancer cell viability. 2021-10-23 2023-08-13 Not clear
Joshua D Brown, Amie J Goodi. Evidence in Context: High Risk of Bias in Medical Cannabis and Cannabinoid Clinical Trials Dictates the Need for Cautious Interpretation. Medical cannabis and cannabinoids. vol 4. issue 1. 2021-10-23. PMID:34676351. evidence in context: high risk of bias in medical cannabis and cannabinoid clinical trials dictates the need for cautious interpretation. 2021-10-23 2023-08-13 Not clear
Robin van Velzen, M Eric Schran. Origin and Evolution of the Cannabinoid Oxidocyclase Gene Family. Genome biology and evolution. vol 13. issue 8. 2021-10-22. PMID:34100927. medicinal and psychoactive effects of cannabis rely on specific terpenophenolic ligands named cannabinoids. 2021-10-22 2023-08-13 Not clear
Robin van Velzen, M Eric Schran. Origin and Evolution of the Cannabinoid Oxidocyclase Gene Family. Genome biology and evolution. vol 13. issue 8. 2021-10-22. PMID:34100927. results show that cannabinoid oxidocyclase genes originated in the cannabis lineage from within a larger gene expansion in the cannabaceae family. 2021-10-22 2023-08-13 Not clear
Robin van Velzen, M Eric Schran. Origin and Evolution of the Cannabinoid Oxidocyclase Gene Family. Genome biology and evolution. vol 13. issue 8. 2021-10-22. PMID:34100927. localization and divergence of oxidocyclase genes in the cannabis genome revealed two main syntenic blocks, each comprising tandemly repeated cannabinoid oxidocyclase genes. 2021-10-22 2023-08-13 Not clear
Robin van Velzen, M Eric Schran. Origin and Evolution of the Cannabinoid Oxidocyclase Gene Family. Genome biology and evolution. vol 13. issue 8. 2021-10-22. PMID:34100927. although wild populations of cannabis are still unknown, increased sampling of landraces and wild/feral populations across its native geographic range is likely to uncover additional cannabinoid oxidocyclase sequence variants. 2021-10-22 2023-08-13 Not clear